Our leases mainly include our worldwide office and research and development facilities which are all classified as operating leases. Certain leases include renewal options that are under our discretion. The leases expire at various dates through fiscal year 2029, some of which include options to extend the lease for up to 5 years. For the six months ended December 26, 2020, we recorded approximately $5.0 million of operating leases expense. Our short-term leases are immaterial and we do not have finance leases.

As of December 26, 2020, the components of leases and lease costs are as follows (in millions):

	December		June
	2020		2020
Operating lease right-of-use assets	$	37.2	$	21.0
Operating lease liabilities	$	10.5	$	6.5
Operating lease liabilities, long-term		28.9		14.6
Total operating lease liabilities	$	39.4	$	21.1

Supplemental cash flow information related to leases is as follows (in millions):

	Six Months Ended
	December
	2020		2019
Cash paid for operating leases included in operating cash flows	$	3.9	$	4.7
Supplemental non-cash information related to lease liabilities arising from obtaining right-of-use assets		21.7	1.5

As of December 26, 2020, the weighted average remaining lease term is 6.2 years, and the weighted average discount rate is 4.02%.

Future minimum lease payments for the operating lease liabilities are as follows (in millions):

	Operating
	Lease
Fiscal Year	Payments
Remainder of 2021	$	6.0
2022		10.2
2023		6.3
2024		4.8
2025		3.9
Thereafter		13.2
Total future minimum operating lease payments		44.4
Less: interest		(5.0	)
Total lease liabilities	$	39.4